Invus Public Equities, L.P. 13D and 13G filings for Solid Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-17 6:50 pm Purchase |
2025-03-31 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 7,415,905 9.600% |
3,666,864![]() (+97.81%) |
Filing |
2025-02-12 4:30 pm Purchase |
2024-12-31 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 3,749,041 9.400% |
1,000,000![]() (+36.38%) |
Filing |
2024-11-12 4:58 pm Purchase |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 2,749,041 7.100% |
240,898![]() (+9.60%) |
Filing |
2024-08-02 6:37 pm Purchase |
2024-07-25 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 2,508,143 6.500% |
2,508,143![]() (New Position) |
Filing |